| Product Code: ETC9690161 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Neuroblastoma Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Neuroblastoma Market - Industry Life Cycle |
3.4 Thailand Neuroblastoma Market - Porter's Five Forces |
3.5 Thailand Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Thailand Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Thailand Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Thailand Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and early detection campaigns for neuroblastoma in Thailand |
4.2.2 Growing investments in healthcare infrastructure and facilities for cancer treatment |
4.2.3 Advancements in research and development leading to innovative treatment options |
4.3 Market Restraints |
4.3.1 Limited access to specialized treatment centers for neuroblastoma |
4.3.2 High treatment costs and lack of insurance coverage for some patients |
4.3.3 Challenges in early diagnosis due to lack of routine screening programs |
5 Thailand Neuroblastoma Market Trends |
6 Thailand Neuroblastoma Market, By Types |
6.1 Thailand Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Thailand Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Thailand Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Thailand Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Thailand Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Thailand Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Thailand Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Thailand Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Thailand Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Thailand Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Thailand Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Thailand Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Thailand Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Thailand Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Thailand Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Thailand Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Thailand Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Thailand Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Neuroblastoma Market Import-Export Trade Statistics |
7.1 Thailand Neuroblastoma Market Export to Major Countries |
7.2 Thailand Neuroblastoma Market Imports from Major Countries |
8 Thailand Neuroblastoma Market Key Performance Indicators |
8.1 Survival rates of neuroblastoma patients in Thailand |
8.2 Number of clinical trials and research studies conducted in the country |
8.3 Percentage of healthcare professionals trained in neuroblastoma treatment and care |
9 Thailand Neuroblastoma Market - Opportunity Assessment |
9.1 Thailand Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Thailand Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Thailand Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Thailand Neuroblastoma Market - Competitive Landscape |
10.1 Thailand Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Thailand Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here